Northern Ireland backs endometriosis care with £1.95 million for specialist and local services
Northern Ireland has committed £1.95 million to endometriosis services in a move designed to improve access to diagnosis, treatment and support for women living with the condition. Health Minister Robbie Butler announced the funding during a visit to the Regional Endometriosis Centre at Belfast City Hospital, where he saw the Da Vinci 5 robotic surgery platform in use for gynaecology care.
The investment is split between the regional and local levels of care. £700,000 will go to the two Regional Endometriosis Centres in the Belfast and Western Trusts, while £1.25 million will be distributed across the five Health and Social Care Trusts to strengthen services and support implementation of a new Regional Endometriosis Pathway.
The policy direction is easy to read at the bedside: women with suspected or confirmed endometriosis need faster movement from symptoms to diagnosis, then from diagnosis to treatment, without repeated delays between services. Endometriosis is not a minor pelvic pain syndrome. It is a chronic condition in which tissue similar to the lining of the womb grows elsewhere in the body, producing severe pelvic pain, fatigue and fertility problems, and often requiring coordinated input from multiple specialties.
Regional centres, robotic surgery and the push for less invasive treatment
The Belfast City Hospital visit also drew attention to surgical capacity already in place. Since the Da Vinci 5 robotic platform launched in May 2026, 130 patients requiring complex surgery have undergone robotic-assisted procedures. The figure matters because complex endometriosis surgery can be technically demanding, especially when disease extends beyond superficial pelvic implants and distorts normal anatomy. Robotic-assisted surgery offers a route to more precise dissection in selected cases, with the potential to reduce tissue trauma and support faster recovery.
Professor Mark Taylor, Regional Clinical Director for Elective Care, linked that capacity to a broader service model built around multidisciplinary working. Endometriosis care often depends on collaboration across hospitals and services, and the expansion of robotic-assisted surgery is being used alongside that model to deliver more complex treatment in less invasive ways.
A single operating list does not solve a chronic disease burden. The practical benefit comes when surgical expertise, outpatient assessment, imaging, triage and postoperative follow-up are aligned so that women are not moved back and forth through fragmented pathways.
Waiting lists have begun to fall, but the pressure remains high
The Department of Health framed the investment as part of a wider effort to improve women’s health services and reduce waiting times across Northern Ireland. Earlier funding of £1.8 million for assessment and triage services and £1.9 million for procedural nursing capacity is already being used to increase access to gynaecology care.
Capacity expansion has also included Gynaecology GP Elective Care Services, additional outpatient clinics, enhanced triage, direct-to-test pathways, more diagnostic services, additional laparoscopy sessions and extra elective theatre sessions. Each of those steps addresses a different bottleneck in the same chain of care. Faster triage shortens the time from referral to first decision; more diagnostics reduce repeated attendances; added theatre sessions allow surgery to happen before symptoms become entrenched or fertility concerns deepen.
Waiting time data suggest early movement in the right direction. Across Northern Ireland, outpatient waiting lists fell from 54,770 in September 2025 to 47,318 in September 2026. The number of patients waiting more than one year for inpatient and day case treatment decreased by 56%. In Belfast Trust, the number of women waiting for a first outpatient gynaecology appointment fell by 4%, and no patient is now waiting longer than 2 years and 10 months for a first appointment. The longest wait for inpatient and day case treatment has dropped from 7 years to 3 years.
Those figures show progress, but they also reveal how prolonged the backlog had become. Endometriosis care is especially vulnerable to delay because pain, heavy periods, bowel or bladder symptoms and fertility concerns can all be misread or normalised before the right referral reaches the right service.
A regional pathway is meant to reduce variation in care
The new funding is being tied directly to a Regional Endometriosis Pathway, a structure intended to improve access and reduce variation across the five Trusts. Variation in this setting can mean different thresholds for referral, different access to imaging or laparoscopy, and different timelines for surgical assessment. A regional pathway offers a framework for standardising those steps so that care depends less on geography and more on clinical need.
The Department of Health is also using the investment to support the Getting It Right First Time report for gynaecology. A Regional Health and Social Care Gynaecology Services Forum has now been established to oversee service improvement and regional delivery. That governance structure matters because service redesign is not finished when funding is announced. Capacity has to be aligned with staffing, theatre scheduling, clinic availability and referral rules if patients are to experience measurable change.
Minister Butler said too many women have experienced long waits for diagnosis and treatment while living with significant pain and uncertainty. He said women deserve timely access to the care and support they need, and described the £1.95 million package as an important step toward improving access to diagnosis, treatment and support through specialist services, local care and a regional pathway.
The clinical weight of endometriosis care is beyond symptom control
Endometriosis affects quality of life in ways that are often undercounted by administrative metrics. Severe pain can disrupt work, sleep, relationships and daily functioning. Fertility problems can add a second layer of distress, while repeated waits can erode trust in the service itself. When referral pathways are slow, patients may spend years cycling through symptom management without a definitive plan.
Robotic surgery and stronger regional coordination will not eliminate the disease burden, but they can change the pace and precision of care. In a condition where anatomy may be distorted and disease may be extensive, less invasive surgery can make the difference between prolonged recovery and earlier return to function, assuming patients are selected appropriately and the service can deliver the necessary expertise.
The investment also sits within a wider elective care strategy supported by the Executive’s £80 million Programme for Government funding package for elective care in 2026/27. In that context, endometriosis is being treated not as an isolated specialty issue but as part of a wider waiting list problem that requires regional coordination, workforce capacity and a clear route from referral to treatment.
What the funding can and cannot do yet
The money will strengthen specialist centres, support local Trusts and help implement a regional pathway, but the core test will be whether those changes continue to pull waiting lists down and shorten the time to first assessment and surgery. Administrative progress is already visible in the waiting list data, and the launch of robotic-assisted surgery has added a new technical tool to the service. The remaining challenge is operational: turning a funding announcement into consistent access across Northern Ireland, with fewer delays and fewer women waiting years for the care they need.